Effect of subanesthetic dose esketamine on anxiety and depression in patients with breast cancer after surgery: a randomized controlled, double-blind study - Top-Institutions - MDSpire

Effect of subanesthetic dose esketamine on anxiety and depression in patients with breast cancer after surgery: a randomized controlled, double-blind study

By
Song-Yuan Liu
Rong Huang
Zhuang Liu
Shou-Shi Wang
Ming-Qiang Zhao
February 9, 2026
0 min

Bmc Psychiatry (Springer)

Share

Top Institutions in Psychiatry

Brief introduction explaining scope and methodology.

#1

Memorial Sloan Kettering Cancer Center

New York, NY
Key Differentiators
- Oncology
- Psychiatry
- Anesthesiology
#2

Dana-Farber Cancer Institute

Boston, MA
Key Differentiators
- Oncology
- Psychiatry
- Pain Management
#3

MD Anderson Cancer Center

Houston, TX
Key Differentiators
- Oncology
- Psychiatry
- Anesthesiology
#4

Massachusetts General Hospital

Boston, MA
Key Differentiators
- Psychiatry
- Anesthesiology
- Oncology
#5

Johns Hopkins Hospital

Baltimore, MD
Key Differentiators
- Oncology
- Psychiatry
- Anesthesiology

Original Source(s)

Bmc Psychiatry (Springer)

Effect of subanesthetic dose esketamine on anxiety and depression in patients with breast cancer after surgery: a randomized controlled, double-blind study

by Song-Yuan Liu, Rong Huang, Zhuang Liu, Shou-Shi Wang, Ming-Qiang Zhao
February 9, 2026

Related Content

Conexiant

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

by Kathryn Wighton
May 27, 2026
5 min

Frontiers In Medicine

Evaluating the impact of integrated care clinics on Asian American populations’ mental health

by Sammi Wong, Christopher Wan, Steven Sust
May 21, 2026

Frontiers In Medicine

When minds and networks matter: how mental health and social capital shape social frailty in older adults